Basket cover image
15 handpicked stocks

U.S. Exporters Target Indonesian Growth

The United States and Indonesia have announced a landmark trade agreement, eliminating tariffs on over 99% of U.S. exports. This deal creates a significant opportunity for American companies in the industrial, food, and technology sectors to expand into a large and growing market.

stock
stock
stock
stock
stock
stock
stock
stock
stock
stock

+5

Author avatar

Han Tan | Market Analyst

Updated 3 days ago | Published at juillet 23

Top Picks from This Group

Here are a few of the assets in this group. Create an account to unlock the full list.

ITW

Illinois Tool Works Inc.

ITW

Current price

$263.94

GFS

GLOBALFOUNDRIES INC.

GFS

Current price

$33.22

HON

Honeywell International Inc.

HON

Current price

$216.74

About This Group of Stocks

1

Our Expert Thinking

The landmark U.S.-Indonesia trade agreement eliminates tariffs on over 99% of American exports, creating a massive opportunity for established U.S. companies. This deal opens access to one of the world's largest and fastest-growing consumer markets, particularly benefiting industrial, food, and technology sectors with the infrastructure to scale quickly.

2

What You Need to Know

These are established American companies with extensive global supply chains and proven ability to expand into new markets. The removal of trade barriers means these firms can now compete more effectively in Indonesia's growing economy, potentially leading to increased sales volumes and revenue growth from reduced export costs.

3

Why These Stocks

Each company was handpicked by professional analysts based on their direct exposure to Indonesian market opportunities. These firms operate in sectors specifically mentioned in the trade agreement and have the operational capacity to capitalize on zero tariffs and simplified regulatory standards that the deal provides.

12 Month Growth Potential

Use the growth calculator to see how much investing in these assets could return over one year.

If you invested across these assets:

in 12 months it could be worth:

$1,000.00

+11.46%

Group Performance Snapshot

11.46%

Average 12 Month Profit

On average, analysts expect assets in this group to grow 11.46% over the next year.

12 of 15

Stocks Rated Buy by Analysts

12 of 15 assets in this group are rated Buy by professional analysts.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Why You'll Want to Watch These Stocks

🚀

First-Mover Advantage

These companies are positioned to be among the first to capitalize on Indonesia's newly opened market. With tariffs eliminated, they can move quickly while competitors are still figuring out their strategy.

🌏

Massive Market Unlock

Indonesia is the world's fourth most populous country with a rapidly growing middle class. This trade deal just opened the door to 270 million potential new customers for American businesses.

💰

Instant Cost Savings

Zero tariffs mean these companies can immediately reduce their export costs and improve profit margins. That's money that goes straight to the bottom line and potentially to shareholders.

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Orphan Drug Moats: Leaders In Rare Disease

Orphan Drug Moats: Leaders In Rare Disease

The FDA's rejection of PTC Therapeutics' drug for a rare genetic disorder has delayed a new treatment option and created a significant setback for the company. This regulatory decision strengthens the competitive position of companies with already-approved therapies for rare diseases, highlighting the value of a proven drug portfolio.

View stocks
Nvidia's China Chip Pivot

Nvidia's China Chip Pivot

Nvidia is developing a new, compliant AI chip for China, aiming to recapture market share lost to U.S. export controls. This strategic pivot creates a ripple effect, potentially benefiting the entire semiconductor supply chain that supports the production and deployment of this advanced hardware.

View stocks
Navigating The Autonomous Driving Shakeout

Navigating The Autonomous Driving Shakeout

A class-action lawsuit against Tesla regarding its Full Self-Driving claims puts the company's marketing and technology under intense scrutiny. This legal challenge could boost demand for competing autonomous driving technologies, creating opportunities for companies that supply advanced sensors and software.

View stocks
View All Stock Groups

Frequently Asked Questions

Everything you need to know about the product and billing.